- A Goldman Sachs economist discussed the economic impact of the opioid crisis in a rare report for a Wall Street investment bank.
- One consequence of drug abuse may be felt in the labor force participation rate, which measures the number of people employed or actively looking for employment.
- The growing opioid epidemic kills more than 90 Americans every day.
The opioid crisis has major costs for the U.S. economy, including the labor market, David Mericle, senior U.S. economist at Goldman Sachs, said in a Wednesday note.
The report is one of the first from a major Wall Street bank focused on the growing epidemic killing more than 90 Americans every day.
"The opioid epidemic is intertwined with the story of declining prime-age participation, especially for men, and this reinforces our doubts about a rebound in the participation rate," Mericle said.
The labor force participation rate, the number of people working or actively looking for work, has fallen since the Great Recession and has stagnated near 63 percent for the last four years, according to the U.S. Bureau of Labor Statistics. This stagnation comes despite monthly jobs reports, such as the one due Friday, showing a steady pace of job creation and a decline in unemployment.
It's a been a puzzle for economists: Why aren't more people actively looking for work again with the job market so strong? Part of the answer may be opioid addiction, the Goldman report suggests.
If the opioid epidemic prevents the participation rate from increasing, the Federal Reserve may not be able to fulfill the full employment part of its dual mandate for achieving a strong economy.
"The economic consequences of the opioid epidemic extend beyond the labor market," Mericle said.
"Recent studies by Birnbaum et al., Rice et al., and Florence et al. estimate sizeable costs of health care, criminal justice, and lost worker productivity," he wrote. "The most recent study put the total cost at $78.5bn in 2013 and the crisis has grown significantly since then, implying substantial costs to both employers and the public sector."
In May, the Fed's Beige Book report on economic conditions also noted that several contacts said job applicants could not pass drug tests for employment, Mericle pointed out. CNBC found that other Beige Books this year did not mention that detail.
Nearly 13 percent, or 12.5 million, of Americans using prescription pain relievers misused them in 2015, he said, citing the National Survey on Drug Use and Health.
"Opioid abuse has been the main contributor to the sharp increase in the rate of drug deaths since 2000," Mericle said, noting drug misuse is more common among men, non-Hispanic whites and those in poverty.
Death rate from drug abuse has exploded over the last 15 years
Source: Centers for Disease Control, Goldman Sachs Global Investment Research
To be sure, the economist believes we would be wrong to assume the rise in drug use is only happening with those out of work. He pointed to a study showing prescription pain reliever abuse is only slightly more common for the unemployed than for the employed.
However, it's clear the recession caused by the housing crisis had an effect on the drug epidemic.
"The recession likely made it worse," Mericle notes.
States across the US are suing Big Pharma over America's worst drug crisis